3115216-45-7

EGFR-IN-213 Chemical Structure
3115216-45-7

Chemical Structure

EGFR-IN-213

  • CAS No.: 3115216-45-7
  • Formula:C35H43Cl3N9O2P
  • Molecular Weight:759.11

InChIKey: CXIZWGKRHNRSMX-UHFFFAOYSA-N

SMILES: CP(C)(C1=CC=CC=C1NC2=NC(NC3=CC(NCC4=C(Cl)C(Cl)=NC=C4)=C(N5CCC(N6CCN(C)CC6)CC5)C=C3OC)=NC=C2Cl)=O

Biological Activity: EGFR-IN-213 is a selective inhibitor of EGFRL858R/T790M/C797S with a human IC50 of 0.48 nM. EGFR-IN-213 acts as an antiproliferative agent, inducing apoptosis and cell cycle arrest, and inhibiting colony formation, cell migration, and tube formation. EGFR-IN-213 can be used for the research of non-small cell lung cancer, chronic myeloid leukemia, gastric cancer, prostate cancer[1].

Cat. No. Product Name Purity Description Pricing
HY-183754
EGFR-IN-213 EGFR-IN-213 is a selective inhibitor of EGFRL858R/T790M/C797S with a human IC50 of 0.48 nM. EGFR-IN-213 acts as an antiproliferative agent, inducing apoptosis and cell cycle arrest, and inhibiting colony formation, cell migration, and tube formation. EGFR-IN-213 can be used for the research of non-small cell lung cancer, chronic myeloid leukemia, gastric cancer, prostate cancer.
Pricing 
Expand Hide
loading...
/
  • /
loading...
Size Price
Stock Quantity Availability Operate
/
In-stock
(Estimated to ship on )
(Estimated to ship TODAY)
Estimated to ship on
(Estimated to ship TODAY)

Amount:

USD 0.00

This product is a controlled substance and not for sale in your territory.

This product is not for sale in your territory.

This compound is listed in the SVHC (Substances of Very High Concern) candidate list of ECHA (European Chemicals Agency).

Pricing 
Expand Hide

References